Sapience Therapeutics Presents First Clinical Results from Phase 2 Study of ST316, First-in-Class β-catenin Antagonist, in Second-Line Colorectal Cancer at the America…

Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide ...
WTOV on MSN

West Virginia launches study for proposed military academy, first class eyed 2028

West Virginia lawmakers are taking early steps toward creating a new four-year military academy in the state, an idea supporters say could offer students a Cita ...
FiercePharma

China approves 4 new drugs, including a global first-in-class medicine

China’s National Medical Products Administration (NMPA) has approved four new drugs developed by local biopharma companies, including a first-of-its-kind molecule in blood cancer. Wednesday, Chinese ...
Nasdaq

Fractyl Health Submits Clinical Trial Application for First-in-Human Study of RJVA-001 Gene Therapy for Type 2 Diabetes and Obesity

Fractyl Health announced a first-in-human trial for RJVA-001, targeting T2D and obesity, pending regulatory approval by 2026. Fractyl Health, Inc. has announced the submission of the first module of ...
The Manila Times

Orvida Pharma (formerly Kamari Pharma) Announces Favorable Phase 1a Safety Data for KM-023, a Potential First-in-Disease Oral TRPV3 Inhibitor, and Initiation of Phase 1b Study ...

Orvida Pharma (formerly Kamari Pharma), a privately held clinical-stage biotechnology company developing first and best-in-class treatments for rare and severe genetic skin diseases, today announced ...